Complete genome sequence of MIDG2331, a genetically tractable serovar 8 clinical isolate of Actinobacillus pleuropneumoniae

摘要

Wellcome Trust provided funding to Paul Coupland and Matthew Holden under grant number 098051. Biotechnology and Biological Sci- ences Research Council (BBSRC) provided funding to Janine T. Bosse, Roy R. Chaudhuri, Yanwen Li, Leon G. Leanse, Roberto Fernandez Cre- spo, Paul Coupland, Matthew Holden, Denise Mara Soares Bazzolli, Dun- can J. Maskell, Dan Tucker, Brendan W. Wren, Andrew N. Rycroft, Paul R. Langford, and BraDP1t Consortium under grant numbers BB/ G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1. Biotech- nology and Biological Sciences Research Council (BBSRC) provided funding to Paul R Langford under grant number BB/K021109/1. MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) provided funding to Denise Mara Soares Bazzolli under grant number PDE 201840/2011-1. This work was supported by a Longer and Larger (LoLa) grant from the Biotechnology and Biological Sciences Research Council (grant numbers BB/G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1), the UK Department for Environment, Food and Rural Affairs, and Zoetis (formerly Pfizer Animal Health) awarded to the Bacterial Respiratory Dis- eases of Pigs-1 Technology (BRaDP1T) consortium, a grant from Con- selho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number PDE 201840/2011-1) awarded to D.M.B., and a BBSRC Imperial-Brazil partnering award (BB/K021109/1) awarded to P.R.L. M.T.G.H. and P.C. were supported by the Wellcome Trust (grant number 098051)